Skip to content

Clinical trials

Phase 3 Cardiomyopathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Phase: Phase 3 Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20042
20072
20092
20101
20122
20132
20141
20172
20181
20193
20204
20211
20232
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting5
Unknown status5
Not yet recruiting2
Active, not recruiting1
Terminated1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals5
Scios, Inc.5
Eidos Therapeutics, a BridgeBio company3
Pfizer2
Ventracor2
Assistance Publique - Hôpitaux de Paris1
Corewell Health East1
Fundación Cardioinfantil Instituto de Cardiología1
I.M. Sechenov First Moscow State Medical University1
Intellia Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies38
Heart Failure14
Amyloidosis10
Renal Insufficiency6
Heart Diseases5
Alzheimer Disease4
Amyloid Neuropathies, Familial4
Amyloidosis, Familial4
Myocarditis3
Cardiomyopathy, Dilated2

Trials

Showing 76 to 38 of 38. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.